Cellectar Biosciences, Inc. announced that on April 29, 2021, Dr. Stephen Hill provided notice to Cellectar Biosciences, Inc. that he will not stand for reelection at the 2021 Annual Meeting of Stockholders. Dr. Hill will continue to serve on the Company’s Board of Directors until the 2021 Annual Meeting of Stockholders, when his current term will expire. Dr. Hill’s decision to not stand for reelection is not the result of any disagreement relating to the Company’s operations, policies or practices. Dr. Hill will continue to serve as chair of the Compensation Committee and a member of the Nominating and Corporate Governance Committee of the Board until the 2021 Annual Meeting of Stockholders.